FDBusiness.com

Study Shows Turmeric Can Reduce Symptoms of Depression, Anxiety Arjuna Targets EU Market with Patented Curcumin

 Breaking News
  • Irish Distillers to Invest €150 Million in Sites in Cork and Dublin Irish Distillers has announced investment of over €150 million in its sites in Cork and Dublin to meet demand for its products as the Irish whiskey renaissance continues apace. This is accelerated by the continued growth of the company’s flagship Jameson brand, which is now in double or triple-digit growth in more than 80 markets [...]...
  • Kepak Sweeps Up Seven Awards at Blas na hEireann Irish meat processor Kepak Group has picked up seven awards at this year’s prestigious Blas na hEireann Irish Food Awards, including a Gold award for its newly launched Centra Irish Angus Sirloin Steaks with Pink Peppercorn Butter. As one of Europe’s leading food innovators, Kepak was up against the top Irish producers in a range of distinct [...]...
  • Chr. Hansen Acquires Dairy Ingredient Supplier Through the acquisition of Austrian-based ingredient supplier Österreichische Laberzeugung Hundsbichler, Chr. Hansen will further expand its enzyme production and presence into the traditional segments of specialty cheeses. Hundsbichler products are widely recognized for high quality, and this acquisition will enable Chr. Hansen to offer cheesemakers a second-to-none product portfolio in the animal rennet space. The acquisition [...]...
  • Croxsons Pulls Out All the Stops For HMS Spirits Company Leading glass packaging company, Croxsons, recently came to the aid of start-up artisan gin distiller, the HMS Spirits Company, to fulfil an urgent packaging requirement. The distiller had found itself without a closure for its latest release, Mary Rose Gin, a small batch London Dry Gin produced to celebrate Henry VIII’s famous warship. The distiller, who [...]...
  • Mains Overtaking Bottled Water Coolers in West Europe 102,500 more water coolers were installed across West Europe in 2017, marking a 3.4% increase and taking the total to 3.1 million, according to a new report from the sector’s leading specialist consultancy Zenith Global. The number of mains water, point of use coolers rose by 6.2% to reach 46.9% of the total, up from [...]...

Study Shows Turmeric Can Reduce Symptoms of Depression, Anxiety Arjuna Targets EU Market with Patented Curcumin

Study Shows Turmeric Can Reduce Symptoms of Depression, Anxiety Arjuna Targets EU Market with Patented Curcumin
November 06
15:01 2015

Kerala, India – Arjuna Natural Extracts Ltd. is targeting the European market with its BCM-95® Curcumin, an all-natural patented formulation of turmeric extract. This ingredient can help mitigate symptoms of depression and anxiety, according to a recent clinical study, further backed by nearly two dozen previous studies supporting the health benefits of BCM-95® Curcumin extract.
The randomized, double-blind, placebo-controlled study of 56 individuals with major depressive disorder was published in June, 2014 by Adrian Lopresti, PhD, et al., of Murdoch University, Australia, in the peer-reviewed Journal of Affective Disorders 167(2014)368–375. Results showed that supplementation with BCM-95 Curcumin succeeded in reducing the overall symptoms of depression, functioning as an anxiolytic as well when taken over a period of 8 weeks. Greater efficacy from curcumin treatment was identified in a subgroup of individuals with atypical depression (common depression). There were no significant differences in the adverse events between BCM-95 and the placebo.
“Curcumin’s positive antidepressant and anti-anxiety effects are likely due to its ability to normalize specific physiological pathways,” says Lopresti. “It appears to elevate neurotransmitters such as serotonin, while lowering stress hormones, such as cortisol, and is a potent antioxidant and anti-inflammatory. Curcumin also provides protection to the brain.”
Depression is a common, treatable disorder that continues to remain under detected globally. Health surveys indicate that major depression is experienced by 10-15% of people in their lifetime. Depression is caused by multiple factors and the success rate of current treatment is only 20-40%. Many treatments are associated with side effects from long-term use, including anxiety, thoughts of suicide, insomnia, weight gain and sexual dysfunction.
Curcumin works simultaneously on multiple pathways associated with depression. It is considered as the most promising therapeutic targets to treat depressive behavior.
BCM-95 curcumin is produced from non-GMO turmeric. It has been extensively researched by universities throughout the US, Australia, Japan and India in multiple clinical studies and has attained 12 international patents.
BCM- 95 curcumin is manufactured by synergistically combining curcumin and essential oil of turmeric, without synthetic additives. The therapeutic benefits of turmeric can be attained at its best by combining curcumin with ar-turmerone, an active compound derived from essential oil of turmeric. In BCM-95, this unique synergy forms a 95% bioactivity enhanced curcuminoid complex to create a highly bioactive turmeric extract with superior bioavailability.
Arjuna’s production processes and products meet market-specific regulations worldwide. A GMP-certified, SAP-driven company, Arjuna has achieved international certifications including ISO22000, Kosher and Halal. Arjuna continues to engage in research and development, with continuing scientific validation of its novel product line through advanced clinical studies.

About Author

editor

editor

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • October 18, 2018Future Food-Tech London - Marketing Partnership
  • October 21, 2018Int'l Food Products Exhibition (Sial)
  • October 25, 2018Italian Espresso Coffee Show (TriestEspresso Expo)
  • October 25, 2018Finnish Food Fair
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements